Anne Hillen

PhD student
Team Member

Short CV

• 2016 – present PhD Candidate Amsterdam UMC, VU Medical Center, NL
• 2013 – 2016 MSc in Neuroscience & Cognition, University of Utrecht, NL
• 2010 – 2013 BSc in (Neuro) Psychology, University of Utrecht, NL

Research

Vanishing White Matter (VWM) is one of the most common leukodystrophies and is caused by a mutation in any of the genes encoding for the five subunits of eIF2B, a protein important in the initiation of translation of mRNA into protein. Although eIF2B is a housekeeping gene, exclusively glial cells in the CNS are affected, with astrocytes driving the loss of white matter. Patients present with progressive motor defects, neurological deterioration, and premature death in children. No curative therapy is available at present; treatment is supportive only. My PhD project aims to develop a gene therapy for VWM through the use of various strategies, including CRISPR-Cas9 technology.

Highlighted publications

• Leferink, P.S.*, Dooves, S.*, Hillen, A.E.J. *, Watanabe, K., Jacobs, G., Gasparotto, L., Cornelissen‐Steijger, P., van der Knaap, M.S. & Heine, V.M. (2019). Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter. Ann Neurol, 86: 780-792. https://doi.org/10.1002/ana.25585

Hillen, A.E.J. & Heine, V.M. (2020). Glutamate Carrier Involvement in Mitochondrial Dysfunctioning in the Brain White Matter. Front. Mol. Biosci., 7: 151. https://doi.org/10.3389/fmolb.2020.00151

Contact info

Address:

Vrije Universiteit Amsterdam
Center for Neurogenomics and Cognitive Research (CNCR)
Department of Complex Trait Genetics
W&N building, Room G-349
De Boelelaan 1085
1081 HV Amsterdam
The Netherlands

Telephone:

+31 20 598 38 50

E-mail:a.hillen@amsterdamumc.nl